English
Home > Products > 269409-70-3

China 269409-70-3 Factory

We emphasize development and introduce new products into the market every year for 269409-70-3,CAS NO 269409-70-3,4-Hydroxyphenylboronic acid pinacol, Living by quality, development by credit is our eternal pursuit, We firmly believe that after your visit we will become long-term partners.
269409-70-3, We're sticking to excellent quality, competitive price and punctual delivery and better service, and sincerely hope to establish long-term good relationships and cooperation with our new and old business partners from all over the world. Sincerely welcome you to join us.

Related Products

Hot Products

  • Cefotetan disodium

    Cefotetan disodium

    Product Name:Cefotetan disodium
    Molecular Formula:C17H18N7NaO8S4
    Molecular Weight;599.6
    CAS Registry Number;74356-00-6
  • Sodium Nitroprusside Dihydrate

    Sodium Nitroprusside Dihydrate

    Product Name:Sodium Nitroprusside Dihydrate
    Molecular Weight:297.95
    CAS Registry Number:13755-38-9
  • (S)-(+)-Mandelic acid

    (S)-(+)-Mandelic acid

    Product Name:(S)-(+)-Mandelic acid
    Molecular Formula:C8H8O3
    Molecular Weight:152.15
    CAS Registry Number:17199-29-0
  • N-(2-Pyrazinylcarbonyl)-L-phenylalanine

    N-(2-Pyrazinylcarbonyl)-L-phenylalanine

    Product Name:N-(2-Pyrazinylcarbonyl)-L-phenylalanine
    Molecular Formula:C14H13N3O3
    Molecular Weight:271.27
    CAS Registry Number:114457-94-2
  • Vilazodone Hydrochloride

    Vilazodone Hydrochloride

    Product Name:Vilazodone Hydrochloride
    Molecular Formula:C26H28ClN5O2
    Molecular Weight;477.98582
    CAS Registry Number;163521-08-2
  • Tetraethylammonium hydroxide

    Tetraethylammonium hydroxide

    Product Name:Tetraethylammonium hydroxide
    Molecular Formula:C8H21NO
    Molecular Weight:147.26
    CAS Registry Number:77-98-5
  • Related Blog
  • Reviews

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

Related Search

CAS NO 269409-70-3

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept